These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 9179528)

  • 1. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD; Brogden RN
    Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
    Berry V; Thorburn CE; Knott SJ; Woodnutt G
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3193-9. PubMed ID: 9835514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
    Darkes MJ; Perry CM
    Am J Respir Med; 2003; 2(2):175-201. PubMed ID: 14720016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of macrolide use in pediatrics.
    Klein JO
    Pediatr Infect Dis J; 1997 Apr; 16(4):427-31. PubMed ID: 9109154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
    Soepandi P; Mangunnegoro H; Yunus F; Gunawan J
    Respirology; 1998 Jun; 3(2):113-7. PubMed ID: 9692520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S; Enzler MJ
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC; Chick TW
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dirithromycin: a new macrolide.
    Wintermeyer SM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
    Peters DH; Clissold SP
    Drugs; 1992 Jul; 44(1):117-64. PubMed ID: 1379907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin and clarithromycin: overview and comparison with erythromycin.
    Whitman MS; Tunkel AR
    Infect Control Hosp Epidemiol; 1992 Jun; 13(6):357-68. PubMed ID: 1320067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiologic activity of the newer macrolide antibiotics.
    McCracken GH
    Pediatr Infect Dis J; 1997 Apr; 16(4):432-7. PubMed ID: 9109155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.
    Dunn CJ; Barradell LB
    Drugs; 1996 Mar; 51(3):483-505. PubMed ID: 8882383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data.
    Carbon C; Poole MD
    J Chemother; 1999 Apr; 11(2):107-18. PubMed ID: 10326741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections.
    Yassin HM; Dever LL
    Expert Opin Investig Drugs; 2001 Feb; 10(2):353-67. PubMed ID: 11178347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in antibacterial choice for lower respiratory tract infections in elderly patients.
    Ferrara AM; Fietta AM
    Drugs Aging; 2004; 21(3):167-86. PubMed ID: 14979735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections.
    Lonks JR; Goldmann DA
    Clin Infect Dis; 2005 Jun; 40(11):1657-64. PubMed ID: 15889365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological profile of telithromycin, the first ketolide antimicrobial.
    Felmingham D
    Clin Microbiol Infect; 2001; 7 Suppl 3():2-10. PubMed ID: 11523558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.